IRIS
GRASSO, Silvana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.976
EU - Europa 11.388
AS - Asia 6.044
SA - Sud America 2.102
Continente sconosciuto - Info sul continente non disponibili 370
AF - Africa 186
OC - Oceania 9
AN - Antartide 1
Totale 40.076
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.716
RU - Federazione Russa 5.380
SG - Singapore 2.367
BR - Brasile 1.841
CN - Cina 1.618
IE - Irlanda 1.461
SE - Svezia 1.244
VN - Vietnam 902
IT - Italia 741
UA - Ucraina 728
DE - Germania 598
HK - Hong Kong 547
FR - Francia 328
FI - Finlandia 303
GB - Regno Unito 275
IN - India 146
CA - Canada 123
AR - Argentina 82
BD - Bangladesh 70
TR - Turchia 69
AT - Austria 51
MX - Messico 49
IQ - Iraq 48
ZA - Sudafrica 47
EC - Ecuador 45
CZ - Repubblica Ceca 42
MA - Marocco 41
NL - Olanda 41
BE - Belgio 40
UZ - Uzbekistan 38
CO - Colombia 35
PL - Polonia 32
VE - Venezuela 31
PK - Pakistan 30
ID - Indonesia 26
ES - Italia 25
IR - Iran 25
CL - Cile 20
JP - Giappone 19
TN - Tunisia 19
JM - Giamaica 18
PE - Perù 17
SA - Arabia Saudita 17
AE - Emirati Arabi Uniti 16
CI - Costa d'Avorio 15
DZ - Algeria 15
PY - Paraguay 15
RO - Romania 13
NP - Nepal 12
TT - Trinidad e Tobago 12
UY - Uruguay 12
LV - Lettonia 11
CH - Svizzera 10
CR - Costa Rica 10
IL - Israele 10
KE - Kenya 10
AZ - Azerbaigian 9
EG - Egitto 9
GE - Georgia 9
MY - Malesia 9
EU - Europa 8
SN - Senegal 8
SV - El Salvador 8
AL - Albania 7
AU - Australia 7
GT - Guatemala 7
HN - Honduras 7
KG - Kirghizistan 7
LT - Lituania 7
BY - Bielorussia 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
JO - Giordania 6
KZ - Kazakistan 6
PA - Panama 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
CW - ???statistics.table.value.countryCode.CW??? 5
GR - Grecia 5
KR - Corea 5
AO - Angola 4
ET - Etiopia 4
GP - Guadalupe 4
KW - Kuwait 4
LB - Libano 4
PH - Filippine 4
PT - Portogallo 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
EE - Estonia 3
LU - Lussemburgo 3
MD - Moldavia 3
NI - Nicaragua 3
OM - Oman 3
RS - Serbia 3
BB - Barbados 2
BG - Bulgaria 2
GA - Gabon 2
HU - Ungheria 2
Totale 39.683
Salva come PNG Salva come JPEG
Città #
Dallas 9.892
Moscow 1.695
Dublin 1.459
Jacksonville 1.383
Singapore 1.232
Ashburn 1.213
Chandler 949
Nyköping 812
Dong Ket 629
Beijing 547
Hong Kong 544
San Jose 523
Council Bluffs 475
Princeton 265
The Dalles 256
Cambridge 255
Medford 232
Lauterbourg 219
Dearborn 216
Los Angeles 200
Des Moines 190
Boardman 160
Ann Arbor 143
Messina 141
São Paulo 122
Buffalo 115
Milan 103
Ho Chi Minh City 98
Tianjin 95
Munich 89
New York 85
San Mateo 75
Lancaster 69
Jinan 68
Hanoi 61
Guangzhou 60
Wilmington 59
Redondo Beach 57
Rio de Janeiro 55
Woodbridge 54
Belo Horizonte 50
Vienna 48
Santa Clara 45
Shenyang 45
Brooklyn 42
Houston 41
Montreal 39
Orem 37
Rome 37
Brussels 36
Nanjing 36
Tashkent 36
Brno 35
Porto Alegre 34
Chicago 32
Frankfurt am Main 32
Shenzhen 32
Columbus 31
Augusta 30
Phoenix 29
Amsterdam 28
Warsaw 28
Haikou 27
Johannesburg 27
Hyderabad 26
Pune 26
Zhengzhou 26
Seattle 25
Helsinki 24
Stockholm 24
Atlanta 23
Brasília 23
Campinas 23
Chennai 22
Curitiba 21
Fuzhou 21
Taizhou 21
Turku 21
Hebei 19
London 19
Mumbai 19
Ningbo 19
Salvador 19
Shanghai 19
St Petersburg 19
Ardabil 18
Baghdad 18
Denver 18
San Francisco 18
Toronto 18
Boston 17
Changsha 17
Tokyo 17
Istanbul 16
Quito 16
Abidjan 15
Da Nang 15
Lima 15
Nanchang 15
Norwalk 15
Totale 26.459
Salva come PNG Salva come JPEG
Nome #
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: synthesis and stereochemistry 4.746
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: stereochemistry and anticonvulsant activity 4.727
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 314
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 304
1-Halophenyl-N-N'-di-(2-heteroaryl)-methylenediamine and 1-halophenyl-3-(2-heteroaryl)-thiazolidin-4-ones as potential hypotensive agents. 283
1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: non-competitive AMPA receptors antagonists 282
1-(2-Fluorophenyl)- and 1-(3-fluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazole 280
1-Aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents 271
1-Adamantanamine derivatives as potential anti-HIV agents 262
1-Halophenyl-N-N'-di-(2-heteroaryl)-methylenediamine and 1-halophenyl-3-(2-heteroaryl)-thiazolidin-4-ones as potential hypotensive agents. 261
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 259
7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists 211
Development of novel Michael acceptors targeting rhodesain as antitrypanosomal agents 208
Cap. 21 - Antitrombotici 205
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 205
2,3,3a,4-Tetraidro-1H-pirrolo[1,2-a]benzimidazol-1-oni 3a-sostituiti 204
3H-AZIRINO[1,2-D][1,4]BENZODIAZEPIN-4 (5H)-ONES - SYNTHESIS AND STEREOCHEMISTRY 199
5H-[1,2,4]OXADIAZOLO[5,4-D][1,5]BENZOTHIAZEPINES - SYNTHESIS AND STEREOCHEMISTRY 197
2,3,3a,4-Tetraidro-1H-pirrolo[1,2-a]benzimidazol-1-oni isomeri ottenuti da 4-cloro-1,2-fenilendiamina ed acidi 3-acilpropionici 193
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 192
3,5-Dihydro-5-methyl-7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel noncompetitive AMPA receptor antagonists 190
3H-Azirino[1,2-d][1,4]benzodiazepin-4(5H)-ones: synthesis and stereochemistry 190
Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors 188
4,4-Methylenedioxybenzene derivatives: synthesis and investigation of the mechanism of their anticonvulsant activity. 179
2,3-Benzodiazepines as potential AMPA receptors antagonists 176
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors. 176
A simple and efficient synthesis of GYKI 52466 and GYKI 52895 174
7,9-Dihydro-1,3-dioxolo[4,5-h][2,3]benzodiazepin-8(7H)-ones as anticonvulsant agents 174
Design, synthesis and biological evaluation of novel dipeptide-like rhodesain inhibitors containing a conformationally constrained 3-bromoisoxazoline warhead 173
13C NMR study of tetrahydrothiazolo[3,2-d][1,4]benzodiazepin-3(2H)-ones. 172
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors 172
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 171
Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening 168
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 167
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors 167
DEVELOPMENT OF NOVEL PEPTIDOMIMETIC ANALOGUES OF A HIGHLY POTENT AND SELECTIVE FALCIPAIN-2 INHIBITOR CONTANING A VINYL ESTER MOIETY 165
Design, synthesis and molecular modeling studies on peptidomimetic vinyl esters as falcipan-2 inhibitors 162
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 161
6,7-Methylenedioxyphtalazin-1(2H)-ones as novel and potent anticonvulsant agents 160
Derivati adamantanici a potenziale attività antivirale. 158
Development of novel amides as non covalent inhibitors of immunoproteasome 158
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives 158
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 157
Evaluation of curcumin irreversibility 157
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 156
Falcipain-2 inhibitors 156
6,7-Methylenedioxyphthalazin-1(2H)-ones as novel and potent anticonvulsant agents 156
Annelated 1,5-benzothiazepines 156
4,5-Methylenedioxybenzene derivatives: synthesis and investigation of the mechanism of their anticonvulsant activity. 155
6,7-Methylenedioxyquinazolin-4-ones as Anticonvulsant Agents 155
AMINOPYRAZINYL DERIVATIVES - SYNTHESIS AND EVALUATION OF ANTIINFLAMMATORY AND RELATED ACTIVITIES 155
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 153
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 152
6,7-Metilendiossiftalazin-1(2H)-oni: una nuova classe di potenti agenti anticonvulsivanti. 151
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 150
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases 149
Development of Novel Peptidomimetics Containing a VinylSulfone Moiety as Proteasome Inhibitors 149
7-Chloro-1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazole and 1-(2,6-difluorophenyl)-6-methyl-1H,3H- thiazolo[3,4-a]benzimidazole 148
Synthesis, Chiral Resolution and Pharmacological Evaluation of a 2,3-Benzodiazepine-Derived Noncompetitive AMPA Receptor Antagonist 148
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 146
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 146
Ciclofunzionalizzazione di 1,4- e 1,5-benzodiazepine: sintesi e stereochimica di nuovi sistemi eteropoliciclici ottenuti per reazione con acidi mercaptoacetici 142
Glutamate Binding-Site Ligands of NMDA Receptors 141
Anti-HIV agents .4. Synthesis and in vitro anti-HIV activity of novel 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazoles 139
Novel peptidomimetics containing different α,β-unsaturated electrophilic functions, as falcipain-2 inhibitors 139
Development of novel N-3-bromoisoxazolin-5-yl substituted 2,3-benzodiazepines as noncompetitive AMPAR antagonists 139
An unexpected reaction between 2,3-dihydro-2,2,4-trimethyl-1H-1,5-benzodiazepine and mercaptoacetic acid 138
Cross-metathesis reactions applications to the synthesis of peptidomimetics as potent falcipain-2 inhibitors 137
2,3-Benzodiazepine-based noncompetitive AMPAR antagonists: design, synthesis, binding affinity and mechanism of inhibition of the GluR2Qflip homomeric receptor channel 137
Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2 ',3 ': 4,5]imidazo[1,2- c]thiazoles 136
Novel potent AMPA/kainate receptor antagonists: Synthesis and anticonvulsant activity of a series of 2-[(4- alkylsemicarbazono)-(4-aminophenyl)methyl]-4,5- methylenedioxyphenylacetic acid alkyl esters 132
Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. 131
Design, synthesis and biological evaluation of peptidomimetics boronic acids targeting 20S proteasome 131
STRATEGIES FOR SYNTHESIS OF CONFORMATIONALLY CONSTRAINED GLUTAMATE ANALOGUES 130
Development of peptidomimetic boronates as proteasome inhibitors 130
Development of Novel Selective Peptidomimetics Containing a Boronic Acid Moiety, Targeting the 20S Proteasome as Anticancer Agents 130
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis 130
Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs) 130
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation 130
Vincamina: sintesi e caratteristiche spettroscopiche 128
Peptidomimetics containing a vinyl ketone warhead as falcipain-2 inhibitors 128
Development of peptidomimetic boronates as proteasome inhibitors 128
ANTI-HIV AGENTS .3. SYNTHESIS AND IN-VITRO ANTI-HIV ACTIVITY OF NOVEL 1H,3H-THIAZOLO[3,4-A]IMIDAZO[4,5-B]PYRIDINES 127
DEVELOPMENT OF NOVEL PEPTIDOMIMETICS CONTAINIG A VINYL SULFONE MOIETY AS PROTEASOME INHIBITORS 126
Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors 124
Synthesis of novel peptidomimetics as inhibitors of protozoan cysteine proteases falcipain-2 and rhodesain 124
Synthesis and anticonvulsant activity of novel and potent 6,7- methylenedioxyphthalazin-1(2H)-ones 123
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli 1-sostituiti 123
Novel peptidomimetics as antiplasmodial falcipain-2 inhibitors 121
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF PEPTIDOMIMETIC FALCIPAIN-2 INHIBITORS AS ANTIMALARIAL AGENTS 121
A simple, one-pot synthesis of novel 1H,3H-thiazolo[3,4-A]benzimidazoles 121
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs) 121
The reaction between 3-acylpropionic acids and the o-phenylenediamine: n.m.r and X-ray analysis of 3a-phenyl-2,3,3a,4-tetrahydropyrrolo[1,2-a]benzimidazol-1-one. 120
Synthesis and anticonvulsant activity of novel and potent 1- aryl-7,8-methylenedioxy-1,2,3,5-tetrahydro-4H-2,3- benzodiazepin-4-ones 120
Structure-activity study of 2,3-benzodiazepin-4-ones noncompetitive AMPAR antagonists: identification of the 1-(4-amino,3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one as neuroprotective agent 120
Synthesis and Molecular Modeling Studies of Derivatives of a Highly Potent Peptidomimetic Vinyl Ester as Falcipain-2 Inhibitors 120
Compounds with potential antitumor activity. Note VIII 1-Alkyl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines. 119
Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors 119
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4- a] benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors 118
NOVEL PYRROLO- AND THIAZOLO-IMIDAZOLES 118
Totale 25.448
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.138
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.138
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.253 0 0 0 70 86 2 103 61 36 61 295 539
2022/20234.222 367 326 182 300 328 467 84 224 1.779 16 98 51
2023/2024847 91 127 69 198 93 92 16 31 4 46 14 66
2024/20254.394 95 44 105 361 205 48 18 1.059 1.223 200 317 719
2025/202620.803 419 3.321 7.312 1.057 853 2.994 1.443 1.414 1.310 367 177 136
2026/20272.048 196 539 620 693 0 0 0 0 0 0 0 0
Totale 40.076